CN104491146A - Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment - Google Patents

Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment Download PDF

Info

Publication number
CN104491146A
CN104491146A CN201410786046.0A CN201410786046A CN104491146A CN 104491146 A CN104491146 A CN 104491146A CN 201410786046 A CN201410786046 A CN 201410786046A CN 104491146 A CN104491146 A CN 104491146A
Authority
CN
China
Prior art keywords
radix
chinese medicinal
treatment
medicinal ointment
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410786046.0A
Other languages
Chinese (zh)
Inventor
朱静
赵兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Bairuiji Biological Engineering Co Ltd
Original Assignee
Qingdao Bairuiji Biological Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Bairuiji Biological Engineering Co Ltd filed Critical Qingdao Bairuiji Biological Engineering Co Ltd
Priority to CN201410786046.0A priority Critical patent/CN104491146A/en
Publication of CN104491146A publication Critical patent/CN104491146A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses traditional Chinese ointment for treating hyperostosis. The traditional Chinese ointment is prepared from the following components by mass: 20-25g of herba epimedii, 20-25g of prepared rehmannia roots, 10-15g of eucommia ulmoides, 10-15g of fructus psoraleae, 10-15g of radix angelicae pubescentis, 10-15g of carthamus tinctorius, 10-15g of asarum sieboldi, 5-10g of scorpio, 5-10g of monkshood, 5-10g of radix aconiti agrestis, 5-10g of pseudo-ginseng, 3-5g of frankincense, 3-5g of myrrh and 3-5g of kudzuvine root. The invention further discloses a preparation method and an application of the traditional Chinese ointment. Due to the medicinal values and the mutual compatibility of the components in the traditional Chinese ointment, the traditional Chinese ointment has the effects of effectively dispersing blood stasis and expelling evil, expelling cold and clearing damp as well as smoothening tendon and dredging collaterals, and has the advantages of good treatment effect and low cost.

Description

Chinese medicinal ointment being used for the treatment of hyperosteogeny and preparation method thereof and application
Technical field
The present invention relates to a kind of Chinese medicinal ointment and preparation method thereof and application, especially a kind of Chinese medicinal ointment for the treatment of hyperosteogeny and preparation method thereof and application, belong to Chinese medicine formula and applied technical field.
Background technology
Bone matrix hyperplasia is mainly in middle age or old people, mainly because body constitution after the middle age dies down, there is degeneration, and due to work or professional reason, be in certain given pose for a long time, cause flesh stiff, or be subject to tractive due to muscle or avulsion, wind and cold etc. cause myelosclerosis, form benefit bone, organization of hematoma, form the hyperosteogeny of thorn-like or lip sample.
In prior art, the medicine for the treatment of hyperosteogeny has a variety of, but curative effect is not very satisfactory, cannot realize the function for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide that a kind of side effect is little, good effect, expense are low, therapeutic effect be significantly used for the treatment of hyperosteogeny Chinese medicinal ointment and preparation method thereof and application.
For solving the problems of the technologies described above, technical scheme of the present invention is:
Be used for the treatment of the Chinese medicinal ointment of hyperosteogeny, it is characterized in that, the formula composition of Chinese medicinal ointment comprises following component and the quality proportioning of each component is:
Herba Epimedii: 20-25g;
Radix Rehmanniae Preparata: 20-25g;
The Cortex Eucommiae: 10-15g;
Fructus Psoraleae: 10-15g;
Radix Angelicae Pubescentis: 10-15g;
Flos Carthami: 10-15g;
Herba Asari: 10-15g;
Scorpio: 5-10g;
Radix Aconiti: 5-10g;
Radix Aconiti Kusnezoffii: 5-10g;
Radix Notoginseng: 5-10g;
Olibanum: 3-5g;
Myrrha: 3-5g;
Radix Puerariae: 3-5g.
Preferably, the formula composition of Chinese medicinal ointment comprises following component and the quality proportioning of each component is: Herba Epimedii: 25g; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 10g; Fructus Psoraleae: 10g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 15g; Herba Asari: 15g; Scorpio: 10g; Radix Aconiti: 10g; Radix Aconiti Kusnezoffii: 5g; Radix Notoginseng: 5g; Olibanum: 5g; Myrrha: 3g; Radix Puerariae: 3g.
Further, the described Chinese medicinal ointment being used for the treatment of hyperosteogeny, also comprises Radix Angelicae Sinensis: 5-10g, Herba Ephedrae 5-10g.
Preferably, the formula composition of Chinese medicinal ointment comprises following component and the quality proportioning of each component is: Herba Epimedii: 25g; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 10g; Fructus Psoraleae: 10g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 15g; Herba Asari: 15g; Scorpio: 10g; Radix Aconiti: 10g; Radix Aconiti Kusnezoffii: 5g; Radix Notoginseng: 5g; Olibanum: 5g; Myrrha: 3g; Radix Puerariae: 3g; Radix Angelicae Sinensis: 5g, Herba Ephedrae 5g.
The above-mentioned manufacture method being used for the treatment of the Chinese medicinal ointment of hyperosteogeny, is characterized in that, by the described quality being used for the treatment of each component in the Chinese medicinal ointment of hyperosteogeny according to after proportioning mixing, makes plaster, often opens containing crude drug 5-10g.
Preferably, described plaster is often opened containing crude drug 8g.
Further, the application of above-mentioned Chinese medicinal ointment on preparation treatment hyperosteogeny medicine.
Beneficial effect of the present invention is: the present invention is by the medical value of each component in Chinese medicinal ointment, and compatibility effect each other, can effectively blood stasis dispelling get rid of evils, expelling cold and dampness, channels sootheing and network vessel quickening, there is good effect, advantage that cost is low.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be described in detail.
As follows for the pharmacology analysis situation of component in Chinese medicinal ointment of the present invention:
Fang Zhong:
Herba Epimedii: acrid-sweet flavor is warm in nature, returns Liver and kidney warp, has effect of expelling wind and removing dampness, kidney invigorating and YANG supporting, rheumatic arthralgia;
Radix Rehmanniae Preparata: sweet, tepor.Returning liver, kidney channel, is use with Radix Angelicae Sinensis mutual reinforcement between, can treating the liver deficiency of the kidney yin, soreness of the waist and knees, osteopyrexia and fever, enhancing immunity;
The Cortex Eucommiae: sweet, temperature.Return liver, kidney channel, liver and kidney tonifying, bone and muscle strengthening, Chong and Ren Meridians regulating, with Fructus Psoraleae compatibility, warming and recuperating the kidney-YANG power increases, hold concurrently spleen reinforcing, liver;
Fructus Psoraleae: bitter, pungent, warm.Return kidney, spleen channel, with Cortex Eucommiae compatibility, can strengthening bone and muscle, arteries and veins of invigorating blood circulation;
Radix Angelicae Pubescentis: can the gas of unimpeded governor vessel bladder, has effect of expelling wind and cold pain relieving, and can priming up;
Flos Carthami: use same with Radix Angelicae Sinensis, has and nourish blood, invigorate blood circulation, effect of removing blood stasis;
Herba Asari: induce sweat cold expelling, wind-expelling pain-stopping is sensible, warming the lung to resolve fluid-retention, can drive the cold of internal organs;
Scorpio: the meridian dredging;
Radix Aconiti: acrid in the mouth, hardship, hot in nature, GUIXIN, liver,kidney,spleen warp, have expelling wind and removing dampness, antalgic, effectively can treat arthralgia; With Herba Ephedrae compatibility, for cold-damp invasion and attack, severe and migratory arthralgia pain, unable to flex and stretch the extremities person;
Radix Aconiti Kusnezoffii: acrid in the mouth, hardship, hot in nature, GUIXIN, liver,kidney,spleen warp, have expelling wind and removing dampness, effect of antalgic, with Radix Aconiti, Olibanum compatibility, to be detained meridians for controlling cold-damp blood stasis, limbs muscle arteries and veins spasm and pain, joint joint stuffiness;
Radix Notoginseng: sweet and slightly bitter taste, property is put down, nontoxic, enters liver, stomach, large intestine channel, has dissipating blood stasis, detumescence, effect of analgesic therapy;
Olibanum: wind of invigorating blood circulation, muscles and tendons relaxing to alleviate pain, has more significant analgesic activity;
Myrrha: bitter in the mouth, flat, nontoxic, enter liver, spleen, the heart, kidney channel, with Flos Carthami compatibility, have invigorate blood circulation, silt of dispelling, stimulate the menstrual flow, effect of pain relieving;
Radix Puerariae: yang invigorating expelling pathogenic factors from muscles, anxious to separate person's back;
Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, with Radix Angelicae Pubescentis compatibility, has calmness, analgesia, antibacterial effect;
Herba Ephedrae: coordinating with our other drug can dispelling the wind and dampness pathogens arthralgia pain and carbuncle of yin nature.
All medicines share above, and can effectively improve microcirculation and alleviate local inflammation reaction, reaching congestion must be capable, and numbness hinders the effect that can lead to, and has significant curative effect to treatment hyperosteogeny.
embodiment 1:
Described is used for the treatment of each component in the Chinese medicinal ointment of hyperosteogeny: Herba Epimedii: 20g; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 12g; Fructus Psoraleae: 12g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 10g; Herba Asari: 15g; Scorpio: 8g; Radix Aconiti: 8g; Radix Aconiti Kusnezoffii: 8g; Radix Notoginseng: 8g; Olibanum: 4g; Myrrha: 4g; Radix Puerariae: 4g makes plaster, often opens containing crude drug 5g after mixing, by plaster outer plaster in sore spot (Ashi point), every day one pastes, and within 10th, is a course for the treatment of, treats 3 courses for the treatment of.
embodiment 2:
Described is used for the treatment of each component in the Chinese medicinal ointment of hyperosteogeny: Herba Epimedii: 22g; Radix Rehmanniae Preparata: 20g; The Cortex Eucommiae: 15g; Fructus Psoraleae: 15g; Radix Angelicae Pubescentis: 10g; Flos Carthami: 12g; Herba Asari: 10g; Scorpio: 5g; Radix Aconiti: 5g; Radix Aconiti Kusnezoffii: 10g; Radix Notoginseng: 10g; Olibanum: 3g; Myrrha: 5g; Radix Puerariae: 5g makes plaster, often opens containing crude drug 10g after mixing, by plaster outer plaster in sore spot (Ashi point), every day one pastes, and within 10th, is a course for the treatment of, treats 3 courses for the treatment of.
embodiment 3:
Described is used for the treatment of each component in the Chinese medicinal ointment of hyperosteogeny: Herba Epimedii: 25g; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 10g; Fructus Psoraleae: 10g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 15g; Herba Asari: 15g; Scorpio: 10g; Radix Aconiti: 10g; Radix Aconiti Kusnezoffii: 5g; Radix Notoginseng: 5g; Olibanum: 5g; Myrrha: 3g; Radix Puerariae: 3g makes plaster, often opens containing crude drug 5-10g after mixing, by plaster outer plaster in sore spot (Ashi point), every day one pastes, and within 10th, is a course for the treatment of, treats 3 courses for the treatment of.
embodiment 4:
Described is used for the treatment of each component in the Chinese medicinal ointment of hyperosteogeny: Herba Epimedii: 22g; Radix Rehmanniae Preparata: 20g; The Cortex Eucommiae: 15g; Fructus Psoraleae: 15g; Radix Angelicae Pubescentis: 10g; Flos Carthami: 12g; Herba Asari: 10g; Scorpio: 5g; Radix Aconiti: 5g; Radix Aconiti Kusnezoffii: 10g; Radix Notoginseng: 10g; Olibanum: 3g; Myrrha: 5g; Radix Puerariae: 5g; Radix Angelicae Sinensis: 10g; Herba Ephedrae 10g makes plaster, often opens containing crude drug 5-10g after mixing, by plaster outer plaster in sore spot (Ashi point), every day one pastes, and within 10th, is a course for the treatment of, treats 3 courses for the treatment of.
embodiment 5:
Described is used for the treatment of each component Herba Epimedii: 25g in the Chinese medicinal ointment of hyperosteogeny; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 10g; Fructus Psoraleae: 10g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 15g; Herba Asari: 15g; Scorpio: 10g; Radix Aconiti: 10g; Radix Aconiti Kusnezoffii: 5g; Radix Notoginseng: 5g; Olibanum: 5g; Myrrha: 3g; Radix Puerariae: 3g; Radix Angelicae Sinensis: 5g; Herba Ephedrae 5g makes plaster, often opens containing crude drug 5-10g after mixing, by plaster outer plaster in sore spot (Ashi point), every day one pastes, and within 10th, is a course for the treatment of, treats 3 courses for the treatment of.
For verifying the clinical effectiveness of invention formulation, carry out clinical experiment.
1, case selection standard:
After the normal experiment inspection of hyperosteogeny, arthroscopy, bone biopsy, x-ray inspection and CT examination, have that joint space is narrow, osteosclerosis, joint margins come to a point, have that hyperosteogeny is formed, the symptoms such as bone blister cavities can be had all as the standard of selection case under heavy burden place cartilage.
2, diagnostic criteria
Affected joints can have persistence dull pain, increase the weight of during movable increase, take a turn for the better after having a rest, increase the weight of when air pressure reduces, acute pain episodes can be had, have joint stiff sense simultaneously, can find that intraarticular has crunch, sitting posterior joint is stiff to be increased the weight of, take a turn for the better after slightly movable, arthroncus, increase and limitation of movement, little complete tetanus, generally shows as bone and blocks symptoms such as levying.
3, therapeutic scheme
The Chinese medicinal ointment that treatment group 160 example loses money in a business described in inventive embodiments 4, every day one, it within 10 days, is a course for the treatment of, use 3 courses for the treatment of, matched group 120 example Tianhe Gutong brute force perspective patch external application affected part, every day one, it within 10 days, is a course for the treatment of, use 3 courses for the treatment of, through statistical analysis, two groups of case-data there was no significant differences (P<0.05).
4, the course for the treatment of evaluation criteria:
Effective: clinical symptom disappearance, local movement is normal, resumes work, and x-ray checks that hyperosteogeny is controlled;
Take a turn for the better: clinical symptom remission, local movement is without obvious restriction, and work is slightly by image, and x-ray checks hyperosteogeny limitation, occasionally has recurrence;
Invalid: after treating 3 courses for the treatment of, clinically have no alleviation, x-ray checks that hyperosteogeny is unchanged;
5, therapeutic effect:
Treatment group: effective 52 examples, effective 79 examples, invalid 29 examples, total effective rate is 81.8%; Matched group, effective 34 example, effective 48 example, invalid 38 example, total effective rate is 68.3%, treatment group total effective rate apparently higher than matched group, specifically in table 1.
A table 1 liang group therapeutic effect compares
Group Number of cases Effective Effectively Invalid Total effective rate (%)
Treatment group 160 52 79 29 81.8
Matched group 120 34 48 38 68.3
The present invention is by the medical value of each component in Chinese medicinal ointment, and compatibility effect each other, can effectively blood stasis dispelling get rid of evils, expelling cold and dampness, channels sootheing and network vessel quickening, there is good effect, advantage that cost is low.
Above detailed description of the invention does not limit the present invention in any form, and every technical scheme obtained in the mode of equivalent replacement or equivalent transformation, all drops in protection scope of the present invention.

Claims (7)

1. be used for the treatment of the Chinese medicinal ointment of hyperosteogeny, it is characterized in that, the formula composition of Chinese medicinal ointment comprises following component and the quality proportioning of each component is:
Herba Epimedii: 20-25g;
Radix Rehmanniae Preparata: 20-25g;
The Cortex Eucommiae: 10-15g;
Fructus Psoraleae: 10-15g;
Radix Angelicae Pubescentis: 10-15g;
Flos Carthami: 10-15g;
Herba Asari: 10-15g;
Scorpio: 5-10g;
Radix Aconiti: 5-10g;
Radix Aconiti Kusnezoffii: 5-10g;
Radix Notoginseng: 5-10g;
Olibanum: 3-5g;
Myrrha: 3-5g;
Radix Puerariae: 3-5g.
2. the Chinese medicinal ointment being used for the treatment of hyperosteogeny according to claim 1, is characterized in that, the formula composition of Chinese medicinal ointment comprises following component and the quality proportioning of each component is: Herba Epimedii: 25g; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 10g; Fructus Psoraleae: 10g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 15g; Herba Asari: 15g; Scorpio: 10g; Radix Aconiti: 10g; Radix Aconiti Kusnezoffii: 5g; Radix Notoginseng: 5g; Olibanum: 5g; Myrrha: 3g; Radix Puerariae: 3g.
3. the Chinese medicinal ointment being used for the treatment of hyperosteogeny according to claim 1, is characterized in that, also comprise Radix Angelicae Sinensis: 5-10g, Herba Ephedrae 5-10g.
4. the Chinese medicinal ointment being used for the treatment of hyperosteogeny according to claim 3, is characterized in that, the formula composition of Chinese medicinal ointment comprises following component and the quality proportioning of each component is: Herba Epimedii: 25g; Radix Rehmanniae Preparata: 25g; The Cortex Eucommiae: 10g; Fructus Psoraleae: 10g; Radix Angelicae Pubescentis: 15g; Flos Carthami: 15g; Herba Asari: 15g; Scorpio: 10g; Radix Aconiti: 10g; Radix Aconiti Kusnezoffii: 5g; Radix Notoginseng: 5g; Olibanum: 5g; Myrrha: 3g; Radix Puerariae: 3g; Radix Angelicae Sinensis: 5g, Herba Ephedrae 5g.
5. the manufacture method being used for the treatment of the Chinese medicinal ointment of hyperosteogeny according to claim 1, is characterized in that, by the described quality being used for the treatment of each component in the Chinese medicinal ointment of hyperosteogeny according to after proportioning mixing, makes plaster, often opens containing crude drug 5-10g.
6. the manufacture method being used for the treatment of the Chinese medicinal ointment of hyperosteogeny according to claim 5, is characterized in that, described plaster is often opened containing crude drug 8g.
7. the application of Chinese medicinal ointment according to claim 5 on preparation treatment hyperosteogeny medicine.
CN201410786046.0A 2014-12-18 2014-12-18 Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment Pending CN104491146A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410786046.0A CN104491146A (en) 2014-12-18 2014-12-18 Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410786046.0A CN104491146A (en) 2014-12-18 2014-12-18 Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment

Publications (1)

Publication Number Publication Date
CN104491146A true CN104491146A (en) 2015-04-08

Family

ID=52932660

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410786046.0A Pending CN104491146A (en) 2014-12-18 2014-12-18 Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment

Country Status (1)

Country Link
CN (1) CN104491146A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105943891A (en) * 2016-06-25 2016-09-21 聂超 Traditional Chinese medicine plaster for relieving pain of hyperostosis
CN106038715A (en) * 2016-06-25 2016-10-26 聂超 Anti-inflammatory and analgesic traditional Chinese medicine plaster for inhibiting hyperostosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1231203A (en) * 1999-03-29 1999-10-13 徐风 Ointment for rheumatic spur
CN101524418A (en) * 2009-04-16 2009-09-09 姜春辉 External herbal medicine for treating rheumatism and manufacture method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1231203A (en) * 1999-03-29 1999-10-13 徐风 Ointment for rheumatic spur
CN101524418A (en) * 2009-04-16 2009-09-09 姜春辉 External herbal medicine for treating rheumatism and manufacture method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王大观: "《本草经义疏》", 31 March 1990 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105943891A (en) * 2016-06-25 2016-09-21 聂超 Traditional Chinese medicine plaster for relieving pain of hyperostosis
CN106038715A (en) * 2016-06-25 2016-10-26 聂超 Anti-inflammatory and analgesic traditional Chinese medicine plaster for inhibiting hyperostosis

Similar Documents

Publication Publication Date Title
CN102552637B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis and preparation method thereof
CN104189871A (en) Medicated wine for treating osteoproliferation
CN103083556B (en) Traditional Chinese medicine for treating cervical spondylosis
CN102526409B (en) Chinese medicinal composition for treating tennis elbow
CN106266939A (en) A kind of Chinese medicine composition, the transdermal patch for neck waist rehabilitation comprising this Chinese medicine composition and preparation and application
CN106039245A (en) External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof
CN104667035A (en) Medicament for treating gout
CN103751290B (en) One treats psoriatic pharmaceutical composition
CN104491146A (en) Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment
CN103285203B (en) Traditional Chinese medicine composition for preventing and treating bone fracture and preparation method thereof
CN103083616B (en) Traditional Chinese medicine for treating ovarian cyst
CN109453460A (en) Remedies hot compress moxibustion matrix, Chinese medicine composition and preparation method containing it
CN101972321B (en) Plaster for treating pains on neck, shoulder, lumbar and legs as well as traumatic injuries
CN104800443B (en) A kind of raw marrow symplectic bone agent of kidney tonifying
CN107184652A (en) A kind of temperature rotation moxa-moxibustion formula
CN105770796A (en) Medicinal liquor liniment for treating soft tissue injury
CN109939214A (en) A kind of Chinese medicine composition of warming and activating meridian, eliminating cold to stop pain
CN104324108B (en) External-use traditional Chinese medicine composition for treating knee osteoarthritis (arthralgia syndrome)
CN106955314A (en) Heat-clearing river Huang of invigorating blood circulation dissipates
CN106177785A (en) A kind of medicine treating cervical spondylosis
CN105943693A (en) Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment
CN1330360C (en) Chinese traditional medicine for treating rheumatoid disease
CN113144064A (en) Wine for treating wind-cold invading muscles and bones and preparation method thereof
CN104257792B (en) For treating sick Chinese medicine composition of numbness and preparation method thereof
CN104758798A (en) Traditional Chinese medicine composition for treating osteoarthrosis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150408